Innovative Leukemia and Lymphoma Therapy (Basic and Clinical Oncology) 1st Edition

  • NH00015803
27 $

by Gertjian J. L. Kaspers (Editor), Bertrand Coiffier (Editor), Michael C. Heinrich (Editor), Elihu H. Estey (Editor)

Innovative Leukemia and Lymphoma Therapy (Basic and Clinical Oncology) 1st Edition

 
by Gertjian J. L. Kaspers (Editor), Bertrand Coiffier (Editor), Michael C. Heinrich  (Editor), Elihu H. Estey (Editor)

Innovative Leukemia and Lymphoma Therapy provides a complete and up-to-date overview of the exciting new treatment modalities in leukemia and lymphoma that are being introduced in the clinic today. Written by international experts in the field, this volume examines clinical studies on topics such as:

 

  • tyrosine kinase inhibitors, histon deacetylase inhibitors, and farnesyl transferase inhibitors
  • radioimmunotherapy, gene-directed therapy, and immunotherapy by vaccination
  • monoclonal antibodies
  • anti-angiogenesis approaches

 

Within each chapter, this well-illustrated, comprehensive source provides a summary of the rationale for treatment, the pathways that are involved, and the translational research to students, scientists, and clinicians. In addition, this book focuses on the concerns of conventional but novel anticancer agents, modulation of classical multidrug resistance, and modulators of single agent drug resistance.


Product details

  • Publisher : CRC Press; 1st edition (May 22, 2008)
  • Language: : English
  • Hardcover : 616 pages